Exelixis, Inc.
EXEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000939767
In the last 90 days, Exelixis, Inc. insiders filed 0 open-market purchases and 1 sale; 760 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
Politicians who traded EXEL
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 4
- Filings
- 1
- Politicians
- 1
- Buys / sells
- 2 / 2
- Estimated volume
- $32.0K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Donna E. Shalala House · FL | 4 | 2 / 2 | $32.0K | Jun 4, 2019 | Apr 27, 2020 |
Trades
Reported trades in Exelixis, Inc., newest filings first.
| Politician | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
Donna E. Shalala House · FL | EXELExelixis, Inc. | Sell | Self | Jun 4, 2019 | Apr 27, 2020 | 328 daysLate | $1K-$15K | Filing |
Donna E. Shalala House · FL | EXELExelixis, Inc. | Sell (partial) | Self | Apr 16, 2019 | Apr 27, 2020 | 377 daysLate | $1K-$15K | Filing |
Donna E. Shalala House · FL | EXELExelixis, Inc. | Buy | Self | Feb 6, 2019 | Apr 27, 2020 | 446 daysLate | $1K-$15K | Filing |
Donna E. Shalala House · FL | EXELExelixis, Inc. | Buy | Self | Jan 9, 2019 | Apr 27, 2020 | 474 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.